Cryoablation for Monomorphic Ventricular Tachycardia (CryoCure-VT)

NAActive, not recruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

May 26, 2021

Primary Completion Date

June 30, 2024

Study Completion Date

September 30, 2024

Conditions
Monomorphic Ventricular Tachycardia
Interventions
DEVICE

Ablation in the ventricles with the Adagio Medical VT Cryoablation System

The Adagio Medical VT Cryoablation System is indicated for the treatment of monomorphic ventricular tachycardia by ablation of arrhythmogenic tissue that drives and maintains these arrhythmias

Trial Locations (7)

9300

Onze Lieve Vrouwziekenhuis, Aalst

Unknown

McGill University Health Centre, Montreal

Montreal Hear Institute, Montreal

Nemocnice na Homolce, Prague

CHU-Bordeaux, Pôle cardio-thoracique, Hôpital Haut-Lévêque, Bordeaux

Herzzentrum Leipzig Universitätsklinik für Kardiologie, Leipzig

St Antonius Ziekenhuis, Nieuwegein

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Adagio Medical

INDUSTRY

NCT04893317 - Cryoablation for Monomorphic Ventricular Tachycardia (CryoCure-VT) | Biotech Hunter | Biotech Hunter